| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.006 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.44 | 0.007 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.11 | 0.008 |